ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling

Zhang, Jianqiang; Ye, Yuedian; Xu, Zhuofan; Luo, Mayao; Wu, Chenwei; Zhang, Yifan; Lv, Shidong*; Wei, Qiang*南方医科大学
Biochemical and Biophysical Research Communications2023-5-7DOI: 10.1016/j.bbrc.2023.02.083
1被引11阅读
引用收藏
分享

摘要

Histone methyltransferase KMT2D plays a critical role as a human oncogene in prostate cancer (PCa). Dysregulated inflammatory responses and cytokine signaling are implicated in cancer progression. Furthermore, interleukin 6 (IL-6) is a pleiotropic cytokine that contributes to PCa progression; however, the association between KMT2D and IL-6 in PCa remains unclear. PCa cell proliferative potential, migratory potential, and apoptosis in vitro were determined using cell counting kit-8 (CCK-8), EdU incorporation, wound healing, and apoptosis assays. Proliferation and migratory potential were impaired and apoptosis was induced in PCa cells cultured with the conditioned medium from KMT2D-depleted cells. Cytokine array analysis showed that IL-6 was the most affected cytokine in the conditioned me-dia. KMT2D knockdown significantly downregulated the expression of IL-6 in PCa cells. What's more, proliferation and migration were also impaired and apoptosis was also induced by silencing IL-6R expression. Immunohistochemistry (IHC) and quantitative reverse transcription-polymerase chain re-action (qRT-PCR) were performed to validate the positive correlation between KMT2D and IL-6 in PCa tissue samples. Chromatin immunoprecipitation (ChIP)-PCR demonstrated that KMT2D and H3K4me1 occupied IL-6 enhancer regions and therefore, directly regulated IL-6 expression. The present study revealed that the KMT2D knockdown suppressed prostate cancer progression through the down -regulation of paracrine IL-6 signaling. These results suggest that KMT2D could be regarded as a potential new target for PCa therapy.

学科与关键词

关键词
KMT2DInterleukin 6Prostate cancerHistone methyltransferase
相关
加载中…
  • Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer
    Zhai, Qiliang; Luo, Mayao; Zhang, Yifan; Zhang, Wenqiang; Wu, Chenwei; Lv, Shidong*; Wei, Qiang*Translational Cancer Research, 2022, 11(8): 2607-+.被引 2
  • The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression
    Yao, Bing; Zhu, Sha; Wei, Xiyi; Chen, Ming-Kun; Feng, Yangkun; Li, Zhimin; Xu, Xinyu; Zhang, Yuwei; Wang, Yang; Zhou, Jingwan; Tang, Ningyuan; Ji, Chengjian; Jiang, Peng; Zhao, Shan-Chao*; Qin, Chao*; Feng, Ninghan*Molecular Cancer, 2022, 21(1): 119.被引 12
  • SETD4 inhibits prostate cancer development by promoting H3K27me3-mediated NUPR1 transcriptional repression and cell cycle arrest
    Wang, Chong; Wang, Tao; Li, Kang-Jing; Hu, Ling-Hong; Li, Yue; Yu, Yu-Zhong; Xie, Tao; Zhu, Sha; Fu, Du-Jiang; Wang, Yang; Zeng, Xian-Zi; Liu, Feng-Ping; Chen, Hong; Chen, Zhe-Sheng; Feng, Ning-Han*; Liu, Jinghua*; Jiang, Yong*; Zhao, Shan-Chao*Cancer Letters, 2023, 579: 216464.
查看全部 →

发表信息

论文状态
公开发表
期刊
Biochemical and Biophysical Research Communications
发表日期
2023-05-07
卷期
第 655 卷
页码
35-43
DOI
10.1016/j.bbrc.2023.02.083
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82103276]; Natural Science Foundation of Guangdong Province [2021A1515011023]

作者

  • Z

    Zhang, Jianqiang (第一作者)

    southern med univ · guangxi univ tradit chinese med

  • Y

    Ye, Yuedian

    southern med univ

查看全部 8 位作者收起作者
  • X

    Xu, Zhuofan

    southern med univ

  • L

    Luo, Mayao

    southern med univ

  • W

    Wu, Chenwei

    southern med univ

  • Z

    Zhang, Yifan

    southern med univ

  • L

    Lv, Shidong (通讯)

    southern med univ

  • W

    Wei, Qiang (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417